You have 9 free searches left this month | for more free features.

long term toxicities

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fasting, Diet, Chemo, Toxicity Trial in Tríkala (fasting diet)

Recruiting
  • Fasting, Diet, Chemotherapy, Toxicity
  • fasting diet
  • Tríkala, Thessaly, Greece
    Department of Nutrition-Dietetics
Aug 27, 2023

Hypertension, Blood Pressure Trial in Kladno (Long-term non-invasive Blood pressure monitoring)

Enrolling by invitation
  • Hypertension
  • Blood Pressure
  • Long-term non-invasive Blood pressure monitoring
  • Kladno, Czechia
    Czech Technical University in Prague
Oct 18, 2023

Long-Term Post Thrombotic Syndrome Assessment.

Recruiting
  • Post Thrombotic Syndrome
  • Phone call
  • Grenoble, France
    ROLLAND
Sep 19, 2023

Breast Cancer Trial in Innsbruck, Linz, Salzburg

Recruiting
  • Breast Cancer
    • Innsbruck, Austria
    • +2 more
    Feb 20, 2023

    Epilepsy Trial (UNEEG EpiSight solution)

    Not yet recruiting
    • Epilepsy
    • UNEEG EpiSight solution
    • (no location specified)
    Jun 22, 2023

    After Removal of Rib Stabilization Hardware in Blunt Chest

    Not yet recruiting
    • Rib Fractures
    • data collection on patient reported long-term outcome of SSRF hardware removal
    • Basel, Switzerland
      Department of Thoracic Surgery, University Hospital Basel
    Aug 14, 2023

    Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve

    Recruiting
    • Long-term Outcomes of Bioprothetic Valve Versus Mechanical Valve
    • valve
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 11, 2023

    Laryngectomy; Status Trial in São Paulo (Provox Life)

    Not yet recruiting
    • Laryngectomy; Status
    • Provox Life
    • São Paulo, Brazil
      Instituto de Cancer Dr. Arnaldo
    Oct 10, 2023

    End Stage Kidney Disease Trial in Huntley (Alio platform)

    Recruiting
    • End Stage Kidney Disease
    • Alio platform
    • Huntley, Illinois
      Site 1
    Sep 21, 2023

    (LTFU) of Patients Treated With Genome-edited Autologous

    Not yet recruiting
    • Sickle Cell Disease
    • OTQ923
    • (no location specified)
    Nov 24, 2023

    Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

    Enrolling by invitation
    • Kidney Transplant Rejection
    • End Stage Renal Disease
    • Urine sample
    • +2 more
    • Leuven, Belgium
    • +5 more
    Aug 3, 2023

    Post-market Multi-Center RETRO-Prospective Study to Assess

    Enrolling by invitation
    • Non-melanoma Skin Cancer
    • Xoft eBx
    • Campbell, California
    • +1 more
    Mar 16, 2022

    Assessment of Long-term Effects of Tachosil

    Completed
    • Fibrin Sealant
    • Haemostasis
    • TachoSil®
    • (no location specified)
    Aug 2, 2023

    Chronic Non-Cancer Pain: Risks and Benefits

    Enrolling by invitation
    • Chronic Non-Cancer Pain
    • Opioid Use Disorder
      • Uppsala, Sweden
        Uppsala Univeristy Hospital
      Sep 25, 2023

      Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in

      Not yet recruiting
      • Knee Osteoarthritis
        • (no location specified)
        Aug 28, 2023

        Elderly, Cancer Surgery, Dexmedetomidine Trial in Beijing, Xi'an, Shanghai (Dexmedetomidine, Placebo)

        Recruiting
        • Elderly
        • +3 more
        • Beijing, Beijing, China, China
        • +2 more
        Sep 14, 2023

        Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course

        Not yet recruiting
        • Locally Advanced Rectal Carcinoma
        • Short course radiotherapy with concurrent capecitabine(825mg/m2)
        • Long course radiotherapy with concurrent capecitabine(825mg/m2)
        • (no location specified)
        Jun 24, 2023

        Long Term Efficacy and Safety Trial (Imlifidase administered in the 20-HMedIdeS-19 (PAES) study, Best available treatment

        Not yet recruiting
        • Long Term Efficacy and Safety
        • Imlifidase administered in the 20-HMedIdeS-19 (PAES) study
        • Best available treatment administered in the 20-HMedIdeS-19 (PAES) study
        • (no location specified)
        Jun 30, 2023

        Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

        Recruiting
        • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
        • 6-month course of antiandrogen drugs
        • Long-term course of antiandrogen drugs
        • Nanjing, Jiangsu, China
          Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
        Jul 13, 2023

        Long Term Follow-Up for RGX-111

        Enrolling by invitation
        • Mucopolysaccharidosis I
        • No Intervention
        • Orange, California
        • +2 more
        Oct 25, 2023

        Morbidity, Long-term Side Effects and Quality of Life in

        Recruiting
        • Germ Cell Tumor
          • Villejuif, France
            Gustave Roussy
          Jun 2, 2023

          Patient With Anti-GABAbr Antibodies Associated-encephalitis.

          Completed
          • Autoimmune Encephalitis
          • Long-term outcome
          • Lyon, France
            Centre de référence des syndromes neurologiques paranéoplasiques
          Feb 14, 2023

          Chronic Venous Insufficiency Trial in Izmir (Training group: Inspiratory muscle training, Control group: Thoracic expansion

          Not yet recruiting
          • Chronic Venous Insufficiency
          • Training group: Inspiratory muscle training
          • Control group: Thoracic expansion exercise
          • İzmir, Turkey
            Izmir Democracy University
          Aug 5, 2023

          Cancer Survivor, Prostate Carcinoma Trial in Duarte (Educational Intervention, Laboratory Biomarker Analysis, Long-term

          Active, not recruiting
          • Cancer Survivor
          • Prostate Carcinoma
          • Educational Intervention
          • +4 more
          • Duarte, California
            City of Hope Medical Center
          Jan 31, 2023

          HIV Trial (CAB LA)

          Not yet recruiting
          • HIV Infections
          • CAB LA
          • (no location specified)
          Nov 21, 2023